Drug Trial Radar · NCT07630727
Study of AHB-171 in Chronic Hepatitis B Participants
Last checked: Nov 19, 2026Latest source record: Jul 21, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
138
Planned (sponsor's estimate)
Start
Jun 24, 2026
Primary completion
Mar 31, 2029
Study completion May 31, 2029
Sponsor
- Lead sponsor
- Ausper Biopharma Co., Ltd.Industry
- Sponsor type
- Industry
- First posted
- Jun 5, 2026
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Non randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The study adopts an open-label, multiple-dose design and aims to evaluate the efficacy and safety of AHB-171 Injection after multiple doses in treatment-naïve (HBeAg-negative/positive) and nucleos(t)ide analogue (NA)-treated (HBeAg-negative) participants with chronic hepatitis B (CHB)
Conditions
- Hepatitis B, Chronic (CHB)
Interventions
AHB-171 InjectionDrug
Subcutaneous injection
Primary outcomes
What the sponsor says the trial is designed to measure.
- Proportion of participants with HBsAg <10 IU/mL and HBV DNA < LLOQ (10 IU/mL)Time frame: Up to 90 days
Locations
10 sites in 1 country. Site status is shown where the registry gives one.
AusperBio Investigational Site
Beijing, Beijing Municipality, China · Recruiting
AusperBio Investigational Site
Chongqing, Chongqing Municipality, China · Recruiting
AusperBio Investigational Site
Xiamen, Fujian, China · Recruiting
AusperBio Investigational Site
Guangzhou, Guangdong, China · Recruiting
AusperBio Investigational Site
Nanning, Guangxi, China · Recruiting
AusperBio Investigational Site
Zhengzhou, Henan, China · Recruiting
AusperBio Investigational Site
Changzhou, Jiangsu, China · Recruiting
AusperBio Investigational Site
Jilin City, Jilin, China · Recruiting
AusperBio Investigational Site
Chengdu, Sichuang, China · Recruiting
AusperBio Investigational Site
Hangzhou, Zhejiang, China · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.